Podcasts about Breast

This week on Hot Topics, Dr. Youn is joined by dermatologist Dr. Emily Levin for a can't-miss conversation. Would you consider a cosmetic treatment that uses fat from an unconventional source? And what does the rise of weight-loss drugs mean for your skin? The doctors tackle these questions and also share stories from recent travels to Japan. Plus, they'll discuss a new breast enhancement technique and a cautionary tale about the dangers of unlicensed cosmetic procedures. Tune in for a fascinating look at the latest trends in cosmetic medicine!

Are environmental toxins quietly slowing your body recomp? Or is the wellness industry selling you fear about things that barely matter?Functional diagnostic nutrition practitioner Michele Scarlet joins me to separate science from hype around metabolism, hormone health, and detox culture. We unpack what the research actually says about pesticides, plastics, cosmetics, and endocrine disruptors, and whether they truly impact weight loss, muscle building, and strength training results.We challenge extreme clean-eating rules, the fear around fruit and sugar, and the obsession with trendy detox protocols. Instead, we focus on practical, evidence-based nutrition and fitness strategies that support metabolism, liver function, and long-term body recomp.If you're lifting weights, dialing in your macros, and still struggling to lose fat or build muscle, this adds the missing layer.Get Fitness Lab (20% off for listeners), the #1 coaching app that adapts to YOUR recovery, YOUR schedule, and YOUR body. Build muscle, lose fat, and get stronger with daily personalized guidance. Timestamps:0:01 – Fear-based marketing in wellness5:43 – Accumulation versus dosage8:48– Ingestion versus exposure11:15 – Cosmetics and chronic absorption13:48 – Endocrine disruption and fat storage21:35 – Breast implants and immune activation28:58 – Why fruit is not the enemy32:39 – When functional lab testing makes sense35:15 – Detox support through nutrition40:02 – How liver detox and bile really work47:48 – When functional lab testing makes senseEpisode resources:The 3 Lab Tests That Changed My Life on True Health PodcastInstagram: @michelescarlet_ Facebook Group: facebook.com/groups/213894783148245 YouTube: @michelescarlet_ 

Listen and subscribe to Money Making Conversations on iHeartRadio, Apple Podcasts, Spotify, www.moneymakingconversations.com/subscribe/ or wherever you listen to podcasts. New Money Making Conversations episodes drop daily. I want to alert you, so you don’t miss out on expert analysis and insider perspectives from my guests who provide tips that can help you uplift the community, improve your financial planning, motivation, or advice on how to be a successful entrepreneur. Keep winning! Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Rhonda Spratt. Founder of Bella Luv, a Georgia‑based nonprofit (referred to in the transcript as Ghost Pink / Bella Luv) dedicated to year‑round breast cancer awareness, early detection advocacy, and compassionate support for women undergoing treatment. Inspired by her mother’s experience and eventual passing from metastatic breast cancer, Spratt explains her mission to move beyond October awareness campaigns and create continuous impact through education, community engagement, and personalized care boxes for women in active treatment. The conversation touches on her personal grief journey, her motivations, the work required to run a nonprofit, her practices for emotional balance, and her vision to normalize year‑round breast cancer education.

Listen and subscribe to Money Making Conversations on iHeartRadio, Apple Podcasts, Spotify, www.moneymakingconversations.com/subscribe/ or wherever you listen to podcasts. New Money Making Conversations episodes drop daily. I want to alert you, so you don’t miss out on expert analysis and insider perspectives from my guests who provide tips that can help you uplift the community, improve your financial planning, motivation, or advice on how to be a successful entrepreneur. Keep winning! Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Rhonda Spratt. Founder of Bella Luv, a Georgia‑based nonprofit (referred to in the transcript as Ghost Pink / Bella Luv) dedicated to year‑round breast cancer awareness, early detection advocacy, and compassionate support for women undergoing treatment. Inspired by her mother’s experience and eventual passing from metastatic breast cancer, Spratt explains her mission to move beyond October awareness campaigns and create continuous impact through education, community engagement, and personalized care boxes for women in active treatment. The conversation touches on her personal grief journey, her motivations, the work required to run a nonprofit, her practices for emotional balance, and her vision to normalize year‑round breast cancer education.

The post 157 Breast Complaints, Cancer Clues & Rewriting Your Study System appeared first on Physician Assistant Exam Review.

Find out about the best food for gut health that acts as a powerful immunity booster and even contains natural stem cells. No supplement or superfood comes close to this healthiest food on Earth! Can you guess what it is?

Pregnancy over 40 is often surrounded by fear, but the real story is more nuanced than most women are told.In Part 2 of our Over 40 series, we break down what actually matters when considering pregnancy later in life, including medical risks, lifestyle factors, birth decisions, and even the surprising benefits of having babies in your 40s.If you've been labeled “advanced maternal age,” feeling pressure about timing, or wondering whether it's too late to grow your family, this episode offers an evidence-based and compassionate perspective.In this episode, we discuss:✔️ Induction pressure and spontaneous labor after 40✔️ How to evaluate pregnancy risks realistically✔️ Miscarriage and chromosomal risk explained simply✔️ When shorter age gaps may make sense biologically✔️ The truth about twins and fertility after 40✔️ Longevity myths — why later fertility may signal better health✔️ Breastfeeding, family planning & timing decisions✔️ Breast cancer risk reduction linked to pregnancy and nursing✔️ Lifestyle factors that matter most in pregnancy after 40✔️ Preconception health, nutrition, and exercise recommendations00:00 Trailer + Podcast Intro01:45 Episode Begins — Pregnancy & Birth Over 40 Overview02:13 Why More Women Are Having Babies After 4003:55 Advanced Maternal Age: What Actually Matters06:02 Chromosomal Risks Explained (Down Syndrome & Testing)08:00 NIPT Testing — Pros, Cons & When It Makes Sense10:14 Twin Pregnancy Risk After 4013:27 Miscarriage Statistics by Age16:54 Pregnancy Complications Over 40 (Hypertension & Preeclampsia)19:35 Placenta Previa Risk Factors21:35 Gestational Diabetes & Lifestyle Factors23:30 Growth Restriction & Paternal Health Influence24:58 Preterm Labor Risk25:47 Stillbirth Risk — What the Numbers Really Mean28:02 Induction & Cesarean Rates After 4030:35 Medical System vs Physiological Birth DiscussionPregnancy outcomes are influenced by far more than age alone: metabolic health, lifestyle, and individualized care play a major role. Whether you're trying to conceive, are currently pregnant, or are simply exploring your options, this episode aims to replace fear with clarity.Watch Part 1 of this series HEREOther Resources Mentioned:Dr. Morgan's 6 Week Pregnancy CallEpisode #31 The Power of ProgesteroneEpisode #150 Everything You Were Never Taught About The PlacentaEpisode #113 Breastfeeding and TTCFind more from Dr. Leah:Dr. Leah Gordon | InstagramDr. Leah Gordon | WebsiteWomanhood Wellness | WebsiteFind more from Dr. Morgan:Dr. Morgan MacDermott | InstagramDr. Morgan MacDermott | WebsiteUse code HEALTHYMOTHER and save 10% at FondUse code HEALTHYMOTHER and save 15% at RedmondFor 20% off your first order at Needed, use code HEALTHYMOTHERSave $260 at Lumebox, use code HEALTHYASAMOTHER

In this episode, Dr. Jockers sits down with Taylor Dukes to unpack her powerful journey of discovering a brain tumor with no symptoms and navigating a glioma diagnosis through faith and integrative care. You'll learn how she approached her diagnosis without fear and why slowing down to seek wisdom changed everything. This conversation reveals what it looks like to trust God while taking bold action.   You'll discover how immune dysfunction, chronic infections, parasites, and toxic burden can create the perfect storm for cancer development. Taylor explains how her tumor likely grew silently for years and how addressing root causes — from gut health to Lyme to detoxification — became central to her recovery. You'll also gain insight into the role of metabolic therapies and nervous system regulation in healing.   You'll learn why removing hidden immune stressors like dental cavitations and breast implants can matter in complex illness. Taylor shares how mindset, identity, and living as if you're healed play a critical role in long-term recovery. This episode leaves space for deeper reflection on resilience, faith, and what true root-cause healing really means.   In This Episode:  00:00 Brain tumor discovered with zero symptoms 00:12 What you'll learn about cancer recovery, gut health, and living without fear 01:35 DrJockers.com resources and health coaching 05:12 Meeting Taylor at Hope for Cancer and her functional medicine background 07:25 Missions abroad, severe illness, and discovering functional medicine 09:00 Preventative MRI reveals a grade 3 brain tumor 10:39 Choosing integrative oncology and shrinking the tumor before surgery 14:54 Brain surgery recovery, neuroplasticity, and a Lyme flare 19:16 How infections, parasites, and immune suppression raise cancer risk 22:19 Three years cancer-free and removing immune stressors 27:10 Breast implants, immune burden, and why she explanted 29:51 Cavitations, sinus issues, and finding the right biological dentist 33:49 Cone beam scans, hidden infections, and patient advocacy 37:03 When to go upstream with functional testing 37:49 The gut as the foundation of health and first healing steps 39:31 Stool testing, SIBO, H. pylori, and why GI-MAP is a favorite 41:17 Why gut healing takes time and how to stay the course 42:05 Raising healthy kids with real food, sleep, and low toxins 46:55 Teaching food literacy with swaps and healthier treats 56:51 Simple supplement routine for kids 01:00:22 Homeschooling, business, and priorities after cancer 01:03:03 Mastering the basics of health and final takeaways   If you want practical, natural strategies to balance your hormones, heal your gut, boost your energy, and slow aging, don't miss The Dr. Josh Axe Show. Dr. Axe blends ancient wisdom with cutting-edge science and brings on world-class experts for unfiltered conversations you won't hear anywhere else. Transform your health from the inside out and subscribe to The Dr. Josh Axe Show, with new episodes every Monday and Thursday.   Fuel your body with Paleo Valley's grass-fed meat sticks, the ultimate healthy snack packed with protein and healthy fats to stabilize blood sugar and satisfy cravings. Made without sugar, additives, or preservatives, these meat sticks are perfect for on-the-go, guilt-free snacking. Choose from flavorful options like original summer sausage, garlic, teriyaki, and jalapeno, in both grass-fed beef and pasture-raised turkey. With an optimal omega-6 to omega-3 ratio, these snacks help reduce inflammation and support immune health, energy, and radiant skin. Ready to try? Visit paleovalley.com/jockers for a 15% discount on PaleoValley today! When it comes to cooking, Chef Foundry offers the perfect solution with their P 600 ceramic cookware, which is free from Teflon, PFAS, and plastic coatings. Made with Swiss-engineered ceramic, this cookware makes it easy to prepare healthy meals without the toxins. Take 20% off with code SAFE20 at chefsfoundry.com/jockers and upgrade your kitchen today.   Support healthy aging from the inside out with Fatty15—a 100% pure, patented, vegan C15 supplement designed to help strengthen cell membranes and support long-term cellular health. Get an additional 15% off the 90-day Subscription Starter Kit when you go to fatty15.com/drjockers and use code DRJOCKERS at checkout.     BON CHARGE's Red Light Face Mask helps to restore glow, calm the complexion, and soften the visible signs of aging – all from the comfort of home. Order yours today and start seeing the amazing skincare benefits. Get 15% off now when you go to https://boncharge.com/ and use my exclusive promo code DRJOCKERS.   "Cancer doesn't just happen—it's a culmination of imbalances, stress, toxins, and immune system breakdown over time."      Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean TuneIn Radio   Resources: Visit paleovalley.com/jockers for a 15% discount  Take 20% off with code SAFE20 at chefsfoundry.com/jockers and upgrade your kitchen today. Visit fatty15.com/drjockers and use code DRJOCKERS at checkout.     Connect with Taylor Dukes: Website - https://taylordukeswellness.com/    Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https://www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/ If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/ 

●       Breast reconstruction → explant journey ●       How the body responds to foreign objects ●       What is Breast Implant Illness (BII)? ●       Genetic sensitivity to implants ●       Why explant surgery doesn't always resolve symptoms ●       Implants and hormonal balance ●       What women should consider before implant surgery ●       The SHARP Method ●       And so much more!   Links mentioned in this episode! Show notes page: https://burnitnutrition.com/podcast196/ . . Get up to 35% off Magnesium Breakthrough Bundles when you order at https://bioptimizers.com/burnit  . . LMNT – Get a free sample pack with your first order – https://drinklmnt.com/burnit . Learn more about Dr. Robert Whitfield: Website: https://www.drrobertwhitfield.com/ . . Podcast Shop Page for Best Deals at https://burnitnutrition.com/shop  . Leave me a rating & review on Apple Podcasts: https://itunes.apple.com/us/podcast/burn-it-nutrition-podcast/id1195955730?mt=2  . Follow Joseph Navarro on Instagram under @BurnitNutrition . Follow Joseph Navarro on Facebook under @BurnitNutrition . Thank You for Listening!! Please share this episode! Be the one who helps spark a transformation in your family! Feedback to share? Send email to info@BurnitNutrition.com Subscribe! Don't miss another episode! Notice of Sponsorship Affiliate Disclosure with BiOptimizers, LMNT,  Fair Use Disclaimer The following podcast episode contains audio clips that are used under the doctrine of fair use as defined by United States copyright law. These clips are used for purposes of commentary, criticism, news reporting, teaching, scholarship, and research. All rights to the original audio content remain with the respective copyright holders. This use is not intended to infringe upon their rights, but to enhance the discussion and understanding of the topic at hand. Please read the full medical disclaimer  burnitnutrition.com/medical-disclaimer/  

Submit your question and we'll answer it in a future episode!Join our Patreon Community!https://www.patreon.com/badassbreastfeedingpodcastToday Dianne and Abby are talking about the recent opinion article from the NewYork Times about equality and formula feeding. Don't miss this episode today asDianne and Abby talk about how feeding a baby does not amount to equality. Didyou read the article? We'd love to hear your thoughts!If you are a new listener, we would love to hear from you.  Please consider leavingus a review on iTunes or sending us an email with your suggestions and commentsto badassbreastfeedingpodcast@gmail.com. You can also add your email to ourlist and have episodes sent right to your inbox!Things we talked about:The NYT Article [6:00]Everything comes down to breastfeeding [9:52]It's just “lovely” [14:40]No benefits to breastfeeding- it's baseline [15:38]“Breast is best” [23:57]Does equality in a marriage come down to bottle feeding? [28:10]Sharing the load/families work it out [32:44]Links to information we discussed or episodes you should check out!https://badassbreastfeedingpodcast.com/episode/combination-feeding-breastmilk-or-formula/https://badassbreastfeedingpodcast.com/episode/010-bottle-feeding-101/Set up your consultation with Diannehttps://badassbreastfeedingpodcast.com/consultations/Check out Dianne's blog here:https://diannecassidyconsulting.com/milklytheblog/Follow our Podcast:https://badassbreastfeedingpodcast.comHere is how you can connect with Dianne and Abby:AbbyTheuring ,https://www.thebadassbreastfeeder.comDianne Cassidy @diannecassidyibclc, http://www.diannecassidyconsulting.comMusic we use:Music: Levels of Greatness from We Used to Paint Stars in the Sky (2012)courtesy of Scott Holmes at freemusicarchive.org/music/ScottHolmes

What does it really mean to own your fertility? In this episode, we're joined by Dr. Jaime Knopman from CCRM Fertility of New York and author of Own Your Fertility, for a candid conversation about egg freezing, fertility preservation, and grief. Dr. Knopman shares what inspired her to write the book, who it's for, and why fertility preservation can be one of the first acts of agency in reproductive health. We unpack common misconceptions about egg freezing. The conversation also turns to a topic often left unspoken: fertility-related grief. Dr. Knopman reflects on how grief shows up when timelines shift and how patients can hold both hope and loss at the same time. This episode is for anyone navigating fertility decisions, questioning timing, or seeking clarity and compassion along the journey. Own Your Fertility is now available on Amazon! Guest: Dr. Jaime Knopman, Board-Certified Reproductive Endocrinologist and Director of Fertility Preservation for CCRM Fertility of New York Hosts:  Dr. Janet Choi, Chief Medical Officer, Progyny Lissa Kline, LCSW, SVP, Provider and Member Services, Progyny --- For more information, visit Progyny's Education page. This show does not constitute medical advice. Be sure to follow us on Instagram, @progynyinc, and subscribe to our YouTube channel for more resources.   Music: YH1DOJKVSNXFR8GG (00:00) - Intro (01:58) - Why egg freezing and grief? (02:26) - Fertility preservation and egg freezing (05:06) - What is a good age to freeze eggs? (07:04) - If I freeze my eggs am I losing eggs? (08:55) - Egg freezing and birth control (09:30) - Breast cancer and fertility preservation (10:00) - Grief and family building (13:28) - The role of partners and community in family building (15:06) - Dr Knopman's Book! (16:12) - Fertility benefits create better outcomes (18:22) - Resilience (00:00) - Chapter 13 (00:00) - Chapter 14

Most symptoms we're dealing with as active women and runners aren't random at all, but are instead clues our body is trying to give us.In this episode, Louise, a multi-award-winning women's integrative health practitioner, shares three powerful lessons from her own health journey and client experiences that every woman should know, especially during perimenopause. She explains how hormone shifts can impact everything from medical testing accuracy to inflammation, fat loss resistance, stress sensitivity, and even unexpected symptoms like canker sores. One key insight is the importance of timing medical screenings, such as breast MRIs, with your menstrual cycle to improve accuracy. Another is the complex relationship between estrogen, histamine, and hormone replacement therapy, and how individual genetics can influence reactions.Louise also highlights how stress, calorie restriction, and hormonal fluctuations can trigger symptoms that seem unrelated, and offers practical strategies to manage acute issues while still addressing root causes like gut health and hormone balance.This episode is a reminder that women's health is highly individualized. Understanding your unique physiology, tracking patterns, and using targeted strategies can help you feel more in control, improve performance, and support long-term health through every stage of life.Explore my "All About Gut Health" and other masterclasses here: https://www.breakingthroughwellness.com/store Link to my FullScript where you can see curated best supplement picks and save 20%: https://us.fullscript.com/welcome/breakingthroughwellness/store-start Learn and level up with my free nutrition guide and award-winning Badass Breakthrough Academy to thrive through perimenopause with less stress: https://www.breakingthroughwellness.com/Take advantage of our podcast listener discount and save 20% off all of Kion's science-backed clean products. Code "LOUISE" saves on all future orders: : https://www.getkion.com/pages/maximizing Episode Highlights:(0:00) Intro(3:05) Three important women's health lessons(6:15) Missed eligibility for early breast screening(9:46) Hormones affecting MRI and mammogram accuracy(13:09) Best timing for breast imaging in cycle(15:10) Hormone optimization and HRT considerations(19:01) Estrogen patch reaction case study(21:58) Estrogen, histamine, and mast cell connection(27:14) Managing histamine overload and recovery(35:24) Stress sensitivity during perimenopause explained(40:00) Hormones, stress, and canker sore triggers(42:49) Gut health and autoimmune connections(46:39) L-lysine for acute outbreak management(51:08) Symptom relief vs root cause approach(52:19) Upcoming resources and listener updates(54:15) OutroTune in weekly to "Maximizing Hormones, Physique, and Running Through Perimenopause" for our simple female-specific science-based revolution. Let's unlock our best with less stress!I'd love to connect! Email

Kapag sinabing Foreplay, kaagad-agad ang naiisip ng marami ay ORAL SEX. Huwag nating kalimutan ang sarap ng magpakalunod sa lambot at bango ng BOOBS. At mapalalaki man, walang Supremo ang hindi nanlambot sa pag-lavish ng kanilang nipples! Hosted on Acast. See acast.com/privacy for more information.

JCO PO author Dr. Foldi at UPMC Hillman Cancer Center and University of Pittsburgh School of Medicine shares insights into the JCO PO article, "Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the Breast." Host Dr. Rafeh Naqash and Dr. Foldi discuss how serial ctDNA testing in patients with mILC is feasible and may enable personalized surveillance and real-time therapeutic monitoring. TRANSCRIPT Dr. Rafeh Naqash: Hello, and welcome to JCO Precision Oncology Conversations, where we bring you engaging conversations with authors of clinically relevant and highly significant JCO PO articles. I am your host, Dr. Rafeh Naqash, podcast editor for JCO Precision Oncology and Associate Professor at the OU Health Stephenson Cancer Center at the University of Oklahoma. Today, we are thrilled to be joined by Dr. Julia Foldi, Assistant Professor of Medicine in the Division of Hematology-Oncology at University of Pittsburgh School of Medicine and the Magee-Womens Hospital of the UPMC. She is also the lead and corresponding author of the JCO Precision Oncology article entitled "Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients with Metastatic Invasive Lobular Carcinoma of the Breast." At the time of this recording, our guest's disclosures will be linked in the transcript. Julia, welcome to our podcast, and thank you for joining us today. Dr. Julia Foldi: Thank you so much for having me. It is a pleasure. Dr. Rafeh Naqash: Again, your manuscript and project address a few interesting things, so we will start with the basics, since we have a broad audience that comprises trainees, community oncologists, and obviously precision medicine experts as well. So, let us start with invasive lobular breast carcinoma. I have been out of fellowship for several years now, and I do not know much about invasive lobular carcinoma. Could you tell us what it is, what some of the genomic characteristics are, why it is different, and why it is important to have a different way to understand disease biology and track disease status with this type of breast cancer? Dr. Julia Foldi: Yes, thank you for that question. It is really important to frame this study. So, lobular breast cancers, which we shorten to ILC, are the second most common histologic subtype of breast cancer after ductal breast cancers. ILC makes up about 10 to 15 percent of all breast cancers, so it is relatively rare, but in the big scheme of things, because breast cancer is so common, this represents actually over 40,000 new diagnoses a year in the US of lobular breast cancers. What is unique about ILC is it is characterized by loss of an adhesion molecule, E-cadherin. It is encoded by the CDH1 gene. What it does is these tumors tend to form discohesive, single-file patterns and infiltrate into the tumor stroma, as opposed to ductal cancers, which generally form more cohesive masses. As we generally explain to patients, ductal cancers tend to form lumps, while lobular cancers often are not palpable because they infiltrate into the stroma. This creates several challenges, particularly when it comes to imaging. In the diagnostic setting, we know that mammograms and ultrasounds have less sensitivity to detect lobular versus ductal breast cancer. When it comes to the metastatic setting, conventional imaging techniques like CT scans have less sensitivity to detect lobular lesions often. One other unique characteristic of ILC is that these tumors tend to have lower proliferation rates. Because our glucose-based PET scans depend on glucose uptake of proliferating cells, often these tumors also are not avid on conventional FDG-PET scans. It is a challenge for us to monitor these patients as they go through treatment. If you think about the metastatic setting, we start a new treatment, we image people every three to four cycles, about every three months, and we combine the imaging results with clinical assessment and tumor markers to decide if the treatment is working. But if your imaging is not reliable, sometimes even at diagnosis, to really detect these tumors, then really, how are we following these patients? This is really the unique challenge in the metastatic setting in patients with lobular breast cancer: we cannot rely on the imaging to tell if patients are responding to treatment. This is where liquid biopsies are really, really important, and as the field is growing up and we have better and better technologies, lobular breast cancer is going to be a field where they are going to play an important role. Dr. Rafeh Naqash: Thank you for that easy-to-understand background. The second aspect that I would like to have some context on, to help the audience understand why you did what you did, is ctDNA, tumor informed and non-informed. Could you tell us what these subtypes of liquid biopsies are and why you chose a tumor informed assay for your study? Dr. Julia Foldi: Yes, it is really important to understand these differences. As you mentioned, there are two main platforms for liquid biopsy assays, circulating tumor DNA assays. I think what is more commonly used in the metastatic setting are non-tumor informed assays, or agnostic assays. These are generally next-generation sequencing-based assays that a lot of companies offer, like Guardant, Tempus, Caris, and FoundationOne. These do not require tumor tissue; they just require a blood sample, a plasma sample, essentially. The next-generation sequencing is done on cell-free DNA that is extracted from the plasma, and it is looking for any cell-free DNA and essentially, figuring out what part of the cell-free DNA comes from the tumor is done through a bioinformatics approach. Most of these assays are panel tests for cancer-associated mutations that we know either have therapeutic significance or biologic significance. So, the results we receive from these tests generally read out specific mutations in oncogenic genes, or sometimes things like fusions where we have specific targeted drugs. Some of the newer assays can also read out tumor fraction; for example, the newest generation Guardant assay that is methylation-based, they can also quantify tumor fraction. But the disadvantage of the tumor agnostic approach is that it is a little bit less sensitive. Opposed to that, we have our tumor informed tests, and these require tumor tissue. Essentially, the tumor is sequenced; this can either be whole exome or whole genome sequencing. The newer generation assays are now using whole genome sequencing of the tumor tissue, and a personalized, patient-specific panel of alterations is essentially barcoded on that tumor tissue. This can be either structural variants or it can be mutations, but generally, these are not driver mutations, but sort of things that are present in the tumor tissue that tend to stay unchanged over time. For each particular patient, a personalized assay, if you want to call it a fingerprint or barcode, is created, and then that is what then is used to test the plasma sample. Essentially, you are looking for that specific cancer in the blood, that barcode or fingerprint in the blood. Because of this, this is a much more sensitive way of looking for ctDNA, and obviously, this detects only that particular tumor that was sequenced originally. So, it is much more sensitive and specific to that tumor that was sequenced. You can argue for both approaches in different settings. We use them in different settings because they give us different information. The tumor agnostic approach gives us mutations, which can be used to determine what the next best therapy to use is, while the tumor informed assay is more sensitive, but it is not going to give us information on therapeutic targets. However, it is quantified, and we can follow it over time to see how it changes. We think that it is going to tell us how patients respond to treatment because we see our circulating tumor DNA levels rise and fall as the cancer burden increases or decreases. We decided to use the tumor informed approach in this particular study because we were really interested in how to determine if patients are having response to treatment versus if they are going to progress on their treatment, more so than looking for specific mutations. Dr. Rafeh Naqash: When you think about these tumor informed assays and you think about barcoding the mutations on the original tumor that you try to track or follow in subsequent blood samples, plasma samples, in your experience, if you have done it in non-lobular cancers, do you think shedding from the tumor has something to do with what you capture or how much you capture? Dr. Julia Foldi: Absolutely. I think there are multiple factors that go into whether someone has detectable ctDNA or not, and that has to do with the type of cancer, the location, right, where is the metastatic site? This is something that we do not fully understand yet: what are tumors that shed more versus not? There is also clearance of ctDNA, and so how fast that clearance occurs is also something that will affect what you can detect in the blood. ctDNA is very short-lived, only has a half-life of hours, and so you can imagine that if there is little shedding and a lot of excretion, then you are not going to be detecting a lot of it. In general, in the metastatic setting, we see that we can detect ctDNA in a lot of cases, especially when patients are progressing on treatment, because we imagine their tumor burden is higher at that point. Even with the non-tumor informed assays, we detect a lot of ctDNA. Part of this study was to actually assess: what is the proportion of patients where we can have this information? Because if we are only going to be able to detect ctDNA in less than 50 percent of patients, then it is not going to be a useful method to follow them with. Because this field is new and we have not been using a lot of tumor informed assays in the metastatic setting, we did not really know what to expect when we set out to look at this. We did not know what was going to be the baseline detection rate in this patient population, so that was one of the first things that we wanted to answer. Dr. Rafeh Naqash: Excellent. Now going to this manuscript in particular, what was the research question, what was the patient population, and what was the strategy that you used to investigate some of these questions? Dr. Julia Foldi: So, we partnered with Natera, and the reason was that their Signatera tumor-informed assay was the first personalized, tumor-informed, really an MRD assay, minimal residual disease detection assay. It has been around the longest and has been pretty widely used commercially already, even though some of our data is still lacking. but we know that people are using this in the real world. We wanted to gather some real-world data specifically in lobular patients. So, we asked Natera to look at their database of commercial Signatera testing and look for patients with stage 4 lobular breast cancer. The information all comes from the submitting physicians sending in pathologic reports and clinical notes, and so they have that information from the requisitions essentially that are sent in by the ordering physician. We found 66 patients who were on first-line or close to first-line endocrine-based therapies for their metastatic lobular breast cancer and had serial collections of Signatera tests. The way we defined baseline was that the first Signatera had to be sent within three months of starting treatment. So, it is not truly baseline, but again, this is a limitation of looking at real-world data is that you are not always going to get the best time point that you need. We had over 350 samples from those 66 patients, again longitudinal ctDNA samples, and our first question was what is the baseline detection rate using this tumor informed assay? Then, most importantly, what is the concordance between changes in ctDNA and clinical response to treatment? That is defined by essentially radiologic response to treatment. Dr. Rafeh Naqash: Interesting. So, what were some of your observations in terms of ctDNA dynamics, whether baseline levels made a difference, whether subsequent levels at different time points made a difference, or subsequent levels at, let us say, cycle three made a difference? Were there any specific trends that you saw? Dr. Julia Foldi: So, first, at baseline, 95 percent of patients had detectable ctDNA, which is, I think, a really important data point because it tells us that this can be a really useful test. If we can detect it in almost all patients before they start treatment, we are going to be able to follow this longitudinally. And again, these were not true baseline samples. So, I think if we look really at baseline before starting treatment, almost all patients will have detectable ctDNA in the metastatic setting. The second important thing we saw was that disease progression correlated very well with increase in ctDNA. So, in most patients who had disease progression by imaging, we saw increase in ctDNA. Conversely, in most patients who had clinical benefit from their treatment, so they had a response or stable disease, we saw decrease in ctDNA levels. It seems that what we call molecular response based on ctDNA is tracking very nicely along with the radiographic response. So, those were really the two main observations. Again, this is a small cohort, limited by its real-world nature and the time points that ctDNA assay was sent was obviously not mandated. This is a real-world data set, and so we could not really look at specific time points like you asked about, let us say, cycle three of therapy, right? We did not have all of the right time points for all of the patients. But what we were able to do was to graph out some specific patient scenarios to illustrate how changes in ctDNA correlate with imaging response. I can talk a little bit about that. Dr. Rafeh Naqash: That was going to be my question. Did you see patients who had serial monitoring using the tumor informed ctDNA assay where the assay became positive a few months before the imaging? Did you have any of those kinds of observations? Dr. Julia Foldi: Yes, so I think this is where the field is going: are we able to use this technology to maybe detect progression before it becomes clinically apparent? Of course, there are lots of questions about: does that really matter? But it seems like, based on some of the patient scenarios that we present in the paper, that this testing can do that. So, we had a specific scenario, and this is illustrated in a figure in the paper, really showing the treatment as well as the changes in ctDNA, tumor markers, and also radiographic response. So, this particular patient was on first-line endocrine therapy and CDK4/6 inhibitor with palbociclib. Initially, she had a low-level detectable ctDNA. It became undetectable during treatment, and the patient had a couple of serial ctDNA assays that were negative, so undetectable. And then we started, after about seven months on this combination therapy, the ctDNA levels started rising. She actually had three serial ctDNA assays with increasing level of ctDNA before she even had any imaging tests. And then around the time that the ctDNA peaked, this patient had radiographic evidence of progression. There was also an NGS-based assay sent to look for specific mutations at that point. The patient was found to have an ESR1 mutation, which is very common in this patient population. She was switched to a novel oral SERD, elacestrant, and the ctDNA fell again to undetectable within the first couple months of being on elacestrant. And then a very similar thing happened: while she was on this second-line therapy, she had three serial negative ctDNA assays, and then the fourth one was positive. This was two months before the patient had a scan that showed progression again. Dr. Rafeh Naqash: And Julia, like you mentioned, this is a small sample size, limited number of patients, in this case, one patient case scenario, but provides insights into other important aspects around escalation or de-escalation of therapy where perhaps ctDNA could be used as an integral biomarker rather than an exploratory biomarker. What are some of your thoughts around that and how is the breast cancer space? I know like in GI and bladder cancer, there has been a significant uptrend in MRD assessments for therapeutic decision making. What is happening in the breast cancer space? Dr. Julia Foldi: So, super interesting. I think this is where a lot of our different fields are going. In the breast cancer space, so far, I have seen a lot of escalation attempts. It is not even necessarily in this particular setting where we are looking at dynamics of ctDNA, but in the breast cancer world, of course, we have a lot of data on resistance mutations. I mentioned ESR1 mutation in a particular patient in our study. ESR1 mutations are very common in patients with ER-positive breast cancer who are on long-term endocrine therapy, and ESR1 mutations confer resistance to aromatase inhibitors. So, that is an area that there has been a lot of interest in trying to detect ESR1 mutations earlier and switching therapy early. So, this was the basis of the SERENA-6 trial, which was presented last year at ASCO and created a lot of excitement. This was a trial where patients had non-tumor-informed NGS-based Guardant assay sent every three to six months while they were on first-line endocrine therapy with a CDK4/6 inhibitor. If they had an ESR1 mutation detected, they were randomized to either continue the same endocrine therapy or switch to an oral SERD. The trial showed that the population of patients who switched to the oral SERD did better in terms of progression-free survival than those who stayed on their original endocrine therapy. There are a lot of questions about how to use this in routine practice. Of course, it is not trivial to be sending a ctDNA assay every three to six months. The rate of detection of these mutations was relatively low in that study; again, the incidence increases in later lines of therapy. So, there are a lot of questions about whether we should be doing this in all of our first-line patients. The other question is, even the patients who stayed on their original endocrine therapy were able to stay on that for another nine months. So, there is this question of: are we switching patients too early to a new line of therapy by having this escalation approach? So, there are a lot of questions about this. As far as I know, at least in our practice, we are not using this approach just yet to escalate therapy. Time will tell how this all pans out. But I think what is even more interesting is the de-escalation question, and I think that is where tumor informed assays like Signatera and the data that our study generated can be applied. Actually, our plan is to generate some prospective data in the lobular breast cancer population, and I have an ongoing study to do that, to really be able to tease out the early ctDNA dynamics as patients first start on endocrine therapy. So, this is patients who are newly diagnosed, they are just starting on their first-line endocrine therapy, and measure, with sensitive assays, measure ctDNA dynamics in the first few months of therapy. In those patients who have a really robust response, that is where I think we can really think about de-escalation. In the patients whose ctDNA goes to undetectable after just a few weeks of therapy with just an endocrine agent, they might not even need a CDK4/6 inhibitor in their first-line treatment. So, that is an area where we are very interested in our group, and I know that other groups are looking at this too, to try to de-escalate therapy in patients who clear their ctDNA early on. Dr. Rafeh Naqash: Thank you so much. Well, lots of questions, but at the same time, progress comes through questions asked, and your project is one of those which is asking an interesting question in a rarer cancer and perhaps will lead to subsequent improvement in how we monitor these individuals and how we escalate or de-escalate therapy. Hopefully, we will get to see more of what you are working on in subsequent submissions to JCO Precision Oncology and perhaps talk more about it in a couple of years and see how the space and field is moving. Thanks again for sharing your insights. I do want to take one to two quick minutes talking about you as an investigator, Julia. If you could speak to your career pathway, your journey, the pathway to mentorship, the pathway to being a mentor, and how things have shaped for you in your personal professional growth. Dr. Julia Foldi: Sure, yeah, that is great. Thank you. So, I had a little bit of an unconventional path to clinical medicine. I actually thought I was going to be a basic scientist when I first started out. I got a PhD in Immunology right out of college and was studying not even anything cancer-related. I was studying macrophage signaling in inflammatory diseases, but I was in New York City. This was right around the time that the first checkpoint inhibitors were approved. Actually, some of my friends from my PhD program worked in Jim Allison's lab, who was the basic scientist responsible for ipilimumab. So, I got to kind of first-hand experience the excitement around bringing something from the lab into the clinic that actually changed really the course of oncology. And so, I got very excited about oncology and clinical medicine. So, I decided to kind of switch gears from there and I went back to medical school after finishing my PhD and got my MD at NYU. I knew I wanted to do oncology, so I did a research track residency and fellowship combined at Yale. I started working early on with the breast cancer team there. At the time, Lajos Pusztai was the head of translational research there at Yale, and I started working with him early in my residency and then through my fellowship. I worked on several trials with him, including a neoadjuvant checkpoint inhibitor trial in triple-negative breast cancer patients. During my last year in fellowship, I received a Conquer Cancer Young Investigator Award to study estrogen receptor heterogeneity using spatial transcriptomics in this subset of breast cancers that have intermediate estrogen receptor expression. From there, I joined the faculty at the University of Pittsburgh in 2022. So, I have been there about almost four years at this point. My interests really shifted slowly from triple-negative breast cancers towards ER-positive breast cancers. When I arrived in Pittsburgh, I started working very closely with some basic and translational researchers here who are very interested in estrogen signaling and mechanisms of resistance to endocrine therapy, and there is a large group here interested in lobular breast cancers. During my training, I was not super aware even that lobular breast cancer was a unique subtype of breast cancers, and that is, I think, changing a little bit. There is a lot more awareness in the breast cancer clinical and research community about ILC being a unique subtype, but it is not even really part of our training in fellowship, which we are trying to change. But I have become a lot more aware of this because of the research team here and through that, I have become really interested also on the clinical side. And so, we do have a Lobular Breast Cancer Research Center of Excellence here at the University of Pittsburgh and UPMC, and I am the leader on the clinical side. We have a really great team of basic and translational researchers looking at different aspects of lobular breast cancers, and some of the work that I am doing is related to this particular manuscript we discussed and the next steps, as I mentioned, a prospective study of early ctDNA dynamics in lobular patients. I also did some more clinical research work in collaboration with the NSABP looking at long-term outcomes of patients with lobular versus ductal breast cancers in some of their older trials. And so, that is, in a nutshell, a little bit about how I got here and how I became interested in ILC. Dr. Rafeh Naqash: Well, thank you for sharing those personal insights and personal journey. I am sure it will inspire other trainees, fellows, and perhaps junior faculty in trying to find their niche. The path, as you mentioned, is not always straight; it often tends to be convoluted. And then finding an area that you are interested in, taking things forward, and being persistent is often what matters. Dr. Julia Foldi: Thank you so much for having me. It was great. Dr. Rafeh Naqash: It was great chatting with you. And thank you for listening to JCO Precision Oncology Conversations. Don't forget to give us a rating or review, and be sure to subscribe so you never miss an episode. You can find all ASCO shows at asco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Breast cancer screening is often treated as a given. Mammograms are framed as routine, early detection as unquestionably life-saving, and following guidelines as the responsible choice. But what if the full picture is more complicated?In this episode of hol+, Dr. Taz sits down with integrative oncologist and breast surgeon Dr. Jenn Simmons, author of The Smart Woman's Guide to Breast Cancer, to explore what breast cancer screening data actually shows, where common narratives may oversimplify reality, and how statistics can sometimes be misunderstood by both patients and providers.Together, they discuss the difference between screening and diagnostic imaging, why detecting more cancers does not always mean fewer deaths, and how concepts like overdiagnosis and lead-time bias shape our interpretation of outcomes. Dr. Jenn also explains how breast cancer behaves differently from many other cancers, why progression is not always linear, and what tumor markers like ER, PR, HER2, and triple-negative really indicate.The conversation expands beyond imaging into a whole-body view of breast health, touching on inflammation, immune function, metabolic health, toxic burden, stress, and lifestyle as factors that shape cancer risk and recovery. Rather than promoting fear or urgency, this episode focuses on helping listeners understand their bodies, ask better questions, and make informed decisions with clarity.This episode is for anyone who wants a deeper understanding of breast cancer screening, feels overwhelmed by conflicting guidance, or wants to approach breast health with more nuance and less panic.About Dr. Jenn SimmonsDr. Jenn Simmons is an integrative oncologist, breast surgeon, and founder of Real Health MD. She was Philadelphia's first fellowship-trained breast surgeon and spent nearly two decades leading one of the region's top breast programs before transitioning into integrative oncology.Drawing from her experience in conventional cancer care and her own health journey, Dr. Simmons now focuses on whole-body approaches to breast health, cancer prevention, and recovery, including metabolic health, inflammation, immune function, lifestyle medicine, and root-cause healing. She is the author of The Smart Woman's Guide to Breast Cancer, a patient-centered resource designed to help women better understand their diagnosis, ask informed questions, and navigate treatment decisions with clarity rather than fear.Order the BookThe Smart Woman's Guide to Breast Cancer Stay Connected:Connect further to Hol+ at https://holplus.co/- Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+.Follow Dr. Jenn SimmonsInstagram: https://www.instagram.com/drjennsimmonsYouTube: https://www.youtube.com/@dr.jennsimmonsWebsite: https://www.jennsimmonsmd.com/Follow Dr. Taz on Instagram: https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Subscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsGet your copy of The Hormone Shift: Balance Your Body and Thrive Through Midlife and MenopauseHost & Production TeamHost: Dr. Taz; Produced by ClipGrowth.com (Producer: Pat Gostek)00:00 Swedish trial claim and overdiagnosis framing 00:52 Why this became a part two conversation 03:25 Reframing screening narratives and medical training gaps 04:39 Why Dr. Simmons questions mammograms as a screening tool 06:06 Origins of screening programs and “invitation to screen” bias 07:12 Relative risk vs absolute numbers example (4 vs 5 per 1,000) 08:49 Overdiagnosis explained with a vivid analogy 09:50 Autopsy-study claim and the “microscopic cancer” idea 12:11 Swedish trial claim revisited: more diagnoses, same deaths 13:38 Downstream harms: callbacks, biopsies, overtreatment 15:04 Lead-time bias and survival statistics explained 16:44 Dr. Simmons' view on the founder's regret narrative 18:16 Switzerland headline clarified and what actually changed 20:10 Cautionary stories and aggressive cancers discussion 22:07 Why breast cancer does not always progress linearly 24:21 Buckets: DCIS, invasive, inflammatory, receptor types 26:15 Clinical vs subclinical disease approach 28:25 Long-term tradeoffs and “forgotten woman” after treatment 32:15 What ER PR HER2 mean biologically and system incentives 35:33 Testosterone discussion and prevention claim presented 42:15 Hormones after breast cancer and the 4-year “reintroduction” idea 44:29 Triple negative: environment, toxicity, immune system focus 49:19 What to do next: pause, exceptions, whole-body workup 52:32 Prevention and breast health approach begins 53:24 At-home tears test explanation (as discussed) 56:24 Detox basics and why sweating is emphasized 59:34 Imaging preferences for screening and what to do if limited access

Dr. Reni Butler speaks with Dr. Anne Marie McCarthy and Dr. Christine Edmonds about their study examining Black–White racial differences in background parenchymal enhancement (BPE) on contrast-enhanced breast MRI. They discuss the finding that black women had higher odds of high BPE independent of breast density, explore potential biologic and environmental drivers, and consider how quantitative BPE assessment could improve breast cancer risk stratification and screening equity. Black-White Racial Differences in Background Parenchymal Enhancement at Breast MRI. Mahmoud et al. Radiology 2026; 318(1):e251041.

Listen and Subscribe to Money Making Conversations on iHeartRadio, Apple Podcasts, Spotify, or wherever you listen to podcasts. New Money Making Conversations episodes drop daily. I want to alert you, so you don’t miss out on expert analysis and insider perspectives from my guests who provide tips that can help you uplift the community, improve your financial planning, motivation, or advice on how to be a successful entrepreneur. Keep winning! Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Rhonda Spratt. Founder of Bella Luv, a Georgia‑based nonprofit (referred to in the transcript as Ghost Pink / Bella Luv) dedicated to year‑round breast cancer awareness, early detection advocacy, and compassionate support for women undergoing treatment. Inspired by her mother’s experience and eventual passing from metastatic breast cancer, Spratt explains her mission to move beyond October awareness campaigns and create continuous impact through education, community engagement, and personalized care boxes for women in active treatment. The conversation touches on her personal grief journey, her motivations, the work required to run a nonprofit, her practices for emotional balance, and her vision to normalize year‑round breast cancer education.

This episode we talk about what we are going through as women in the aging game. You may have heard it before but part of aging is forgetting stuff... Sit back and have a laugh with us because really that is all you can do in the process. 

Breast cancer screening fails most often where access is constrained: limited appointments, geographic gaps, dense breast tissue, and reliance on self-exams that depend entirely on human touch. Awareness alone doesn't close those gaps.In this episode, Dr. Karny Ilan, co-founder and CEO of Feminai, shares how physician-led product design, multidisciplinary collaboration, and rigorous clinical trials shaped a new model for breast screening access. The conversation explores a shift in how breast health is managed—from episodic screening to continuous, individualized monitoring. Rather than relying on infrequent appointments alone, it examines tools designed to track changes over time, at home, while remaining connected to clinical decision-making. Timestamps(00:11) Breast cancer risk shaped by genetics and lived exposure(08:37) Limits of traditional self-breast exams(09:09) Personal experience shaping breast health urgency(10:15) How at-home breast scanning detects change over time(12:42) Designing screening tools for dense breast tissue(17:03) Addressing breast size, shape, and post-surgical variation(18:31) Clinical trials revealing real-world usability gaps(20:13) Why ease of use affects screening reliability(29:29) Access gaps amplified by pandemic-era screening delays(38:09) Broad inclusion across age, risk, and body types Guest BioDr. Karny Ilan — Co-Founder and CEO, FeminaiDr. Karny Ilan is a general surgery resident at Sheba Medical Center and the co-founder and CEO of Feminai, a breast health company developing an AI-enabled disposable wearable patch and app for at-home breast exams. With a strong family history of breast cancer, she brings clinical experience and patient-centered design to building scalable screening tools that expand access and personalization.LinkedIn: https://www.linkedin.com/in/karny-ilan/Key PointsAccess constraints drive missed detection: Feminai targets screening gaps caused by geography, capacity, and avoidance.Physician-led design builds trust: Clinical credibility accelerated adoption with providers and investors.Dense breast tissue is a priority use case: The technology is designed to perform well where mammography often struggles.Personalized baselines change detection logic: Each scan is compared against the user's own prior data.Usability directly affects accuracy: Instructions, fit, and behavior shape downstream AI performance.Deep Dives1. At-home breast exams as infrastructureDesigned for frequent, low-friction useComplements rather than replaces imaging2. Patch and app workflowRisk stratification via medical questionnaireBluetooth-enabled scan uploads to secure cloudAI analysis with physician review3. Designing for every bodyStretch materials accommodate size variationDense tissue explicitly accounted forAdditional sizes planned as rollout expands4. Clinical trials beyond performance metricsUsability drove multiple design iterationsInstruction format affected adherenceShape changes required algorithm updates5. Personalized longitudinal trackingEach woman compared only to herselfChanges flagged based on deviation, not population averages6. Leadership and multidisciplinary teamsEngineers exposed to clinical sitesPatient stories shared to reinforce missionStability in leadership communication protected executionLinks & ReferencesBreast cancer screening beyond mammography (Mayo Clinic): https://www.mayoclinic.org/tests-procedures/mammogram/in-depth/breast-cancer/art-20047233Breast cancer screening recommendations (USPSTF): https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening

■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ あと９０曲となりました！！　 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■he holds her helpless breast upon his breast - #4446 (98R02 percent 90 left) by chair house 260215.mp3he holds her helpless breast upon his breast■ＰＳ１：今日は急遽ちびさ..

*** ONLY 90 SONGS LEFT!! *** means only 90 days.. : ) he holds her helpless breast upon his breast - #4446 (98R02 percent 90 left) by chair house 260215 (again, William Butler Yeats from May 22, 2025) *** NEW CATCHPHRASE FOR PIANO TEN THOUSAND LEAVES *** " Gentleness, carried on 4,536 leaves of sound " =========================== The Complete Works of Piano Ten Thousand Leaves Vol.1-5 =========================== VOLUME1-5 just released! Gentleness, carried on 4,536 leaves of sound. --- youtube full video: https://youtu.be/keXS3AEO1a4 --- spotify: https://open.spotify.com/intl-ja/album/4bNp2s3LQmQRKW20I9nqg6?si=J3ecOB_ySXKqrtjWViXNgA --- Apple Music: https://music.apple.com/jp/album/the-complete-works-of-piano-ten-thousand-leaves-vol-1-5/1851196335 --- amazon Music: https://amazon.co.jp/music/player/albums/B0G14M9TRF?marketplaceId=A1VC38T7YXB528&musicTerritory=JP&ref=dm_sh_AW167RpyD3hxpUR2jIAjg0SRa --- Line Music: https://music.line.me/webapp/album/mb0000000004ca05e8 --- AWA: https://s.awa.fm/album/79acc2b85cbe01e0a992 --- all music streaming services: https://linkco.re/GqnQvNyP?lang=en ######## Latest Album: 31st SELECTION ALBUM JUST RELEASED ######## "forest moon dream" - the 31st selection album of piano ten thousand leaves youtube: FULL VIDEO with 20 full songs in very high quality sounds https://youtu.be/hRY7rtkp-hw?si=dpSjSeY7rHAyOvtC spotify: https://open.spotify.com/intl-ja/album/0GL5j2gohVbt5rgcbZqslM?si=Al-XczUJTJmNYgpcGbff7w apple Music: https://music.apple.com/jp/album/forest-moon-dream/1843588627 amazon music: https://amazon.co.jp/music/player/albums/B0FTMBPY75?marketplaceId=A1VC38T7YXB528&musicTerritory=JP&ref=dm_sh_dz30EicNlOoEQrCadNDGVEtSW all music streaming services: https://linkco.re/GzFhAvTg?lang=en *** "PIANO TEN THOUSAND LEAVE" COMPLETE WORK ALBUM SERIES START *** Now begins a new challenge: to compile all 4,536 pieces into 91 albums and deliver them to the future. Just as "Ten Thousand Leaves ( Manyoushu ) " carried the hearts of lovers across a thousand years, we hope these piano pieces will reach people a thousand years from now. =================== VOLUME1-5 =================== See the description above. =================== VOLUME1-4 =================== *** youtube full video: https://youtu.be/a77YDMMgv7o *** spotify: https://open.spotify.com/intl-ja/album/3mISdsZNVdEAD2BMxCE0ku?si=2l36hot_TsyV_kCVnKwLBg *** Apple Music: https://music.apple.com/jp/album/the-complete-works-of-piano-ten-thousand-leaves-vol-1-4/1840586819 *** amazon Music: https://amazon.com/music/player/albums/B0FRMNGD1K?marketplaceId=ATVPDKIKX0DER&musicTerritory=US&ref=dm_sh_mFt4isWbmtWKlgKqqHDbRNiff *** all music streaming services: https://linkco.re/m0nqEtsg?lang=en =================== VOLUME1-3 =================== *** youtube full video https://youtu.be/ue7KsUBdLME?si=5UbdJelOAPjqboiJ *** spotify: https://open.spotify.com/intl-ja/album/6BAV5XloL6HDGboFeiE3VF?si=e4E-3zI0RqCt8aQNrnMHrQ *** Apple Music: https://music.apple.com/jp/album/the-complete-works-of-piano-ten-thousand-leaves-vol-1-3/1834912123 *** all music streaming services: https://linkco.re/8RNRdEa3?lang=en =================== VOLUME1-2 =================== *** youtube: full video of 50 pieces 2 hours https://youtu.be/fBmIMLpM10g?si=MQmAdF95M7GCm4Ve *** spotify: https://open.spotify.com/intl-ja/album/1KDM283kVS8x7fO9q79w2v?si=iIJ4sZidSqWW8ah59Y_a1g *** Apple Music: https://music.apple.com/jp/album/the-complete-works-of-piano-ten-thousand-leaves-vol-1-2/1832629621 *** all music streaming services: https://linkco.re/VeA0UreQ?lang=en =================== VOLUME1-1 =================== *** youtube: full video of 50 pieces 2 hours https://youtu.be/YERNF74cvKw?si=6FiU67TOdybggkQk *** spotify: https://open.spotify.com/intl-ja/album/12vCnNiO4EfBz6eVPGhvOr?si=P3cL7RZSTV-87jeswyI8BA *** Apple Music: https://music.apple.com/jp/album/the-complete-works-of-piano-ten-thousand-leaves-vol-1-1/1831717286 *** all music streaming services: https://linkco.re/Y9VNVN23

Botox toxicity. Breast implant illness. Immune system reactivity. Post-COVID inflammation. In this episode of The Health Revival Show, we break down the real science behind cosmetic procedures and why some people tolerate Botox and breast implants perfectly… while others develop systemic symptoms. We cover: • How Botox works as a neurotoxin • Breast implant illness vs immune reactivity • Terrain theory and why host health matters more than exposure • Genetic detox pathways and inflammatory risk markers • Mast cell activation, histamine intolerance, and post-viral sensitivity • When cosmetic procedures are lower risk — and when to wait If you've ever wondered whether Botox or implants are “toxic”… this conversation will change how you think about risk, immunity, and personalized health decisions. *** CONNECT:

In this episode of the progesterone series, Dr. Brendan McCarthy — Chief Medical Officer of Protea Medical Center in Tempe, Arizona — explores the often misunderstood relationship between progesterone, estrogen, and breast health. For decades, women have been taught to fear their breasts and fear hormones. While awareness matters, fear is disempowering — and it has left many women confused about what's actually happening in their bodies. In this episode, we discuss: Why breast tissue is dynamic, not static How estrogen stimulates growth and progesterone restores balance The role of progesterone in breast tissue maturation and architecture Why dense or fibrocystic breasts often reflect unopposed estrogen How restoring ovulation and progesterone can reduce breast pain and density in some women The difference between natural progesterone vs synthetic progestins Where the fear around progesterone and breast cancer really came from Progesterone is not something to fear — it is a hormone of organization, balance, and maturation. Understanding how it works allows women to approach breast health with clarity instead of anxiety.

My next guest wanted to go public with her story so that other women who have undergone plastic surgery might feel empowered to undergo a cosmetic reversal. Joining Sean was Sarah Lavender Smith, a writer and mountain ultra runner from Colorado.

In this insightful episode, Dana Irvine dives deep into breast health, emphasizing the critical importance of holistic breast care for women over 40. She shares empowering knowledge on how to manage menopause symptoms effectively while supporting women's overall wellness through self-breast exams, thermography, and gentle detoxification. Learn about the vital role of the lymphatic system, hormone balance, and emotional well-being in maintaining breast health as part of empowered aging women's health strategies.Dana provides practical daily tips and holistic approaches to promote lifelong breast wellness, combining functional nutrition and hormone support to help women regain vitality. This conversation is an essential guide for women seeking menopause support and looking to boost their libido, health, and confidence during this transformative stage of life.Tune in to discover how creating a personalized breast health routine enhances emotional and physical well-being, emIf today's episode spoke to you, I invite you to take the next step.Subscribe to the Wise Divine Women PodcastShare this episode with a woman you loveLeave a reviewVisit WiseDivineWomen.com for resources to support your health journey.If you're ready for more personalized guidance, you can also schedule a Wise Divine Women's Health Strategy Call to empower you to take control of your body with greater awareness and grace.Takeaways1. Breast health education is crucial for women, especially over 40.2. Self-breast exams help women understand their bodies better.3. The lymphatic system plays a vital role in breast health.4. Gentle detoxification can support breast wellness.5. Daily practices can enhance breast health and emotional well-being.6. Emotions can manifest physically in breast tissue.7. Thermography offers insights into breast health.8. Functional nutrition can aid in hormone balance and overall health.9. Creating a breast health routine is essential for self-care.10. Awareness and education empower women to take charge of their health.Chapters00:00 Introduction to Breast Health Awareness02:18 Understanding Breast Health After 4004:45 The Importance of Lymphatic Health07:25 Gentle Breast Detox and Daily Support10:02 Emotional Well-being and Breast Health12:45 Self-Breast Exams: A Guide15:14 Creating a Breast Health Ritual18:13 Thermography and Functional Nutrition20:38 Conclusion and Call to ActionKeywordsbreast health, thermography, lymphatic system, self-breast exam, holistic nutrition, women's health, hormone balance, detoxification, emotional wellbeing, wellness education

In this episode, host Don Adeesha joins Dr. Milind Kachare, a plastic surgeon at Nayak Plastic Surgery, to dissect the "high-performance associate" model. Dr. Kachare explains his "practice within a practice" approach, detailing how he carved out a distinct Breast and Body lane within a predominantly facial surgery ecosystem. He shares the critical preparatory steps he took before day one, including establishing specific protocols and consents, to ensure he could generate his own leads rather than relying solely on the founder's overflow. Dr. Kachare breaks down how to leverage academic weight in a market saturated with social media trends. He argues that while patients may not count publications, they value the translation of that data into understandable safety assurances. He illustrates this with a dramatic case study involving a gunshot wound to an implant, showing how evidence-based storytelling can prove product integrity and empower patients to make decisions, ultimately justifying premium positioning. Finally, the discussion turns to recruitment and culture, exploring why top talent chooses long-term commitment over short-term stepping stones. Dr. Kachare highlights the importance of transparency and the "green flag" of a founder who prioritizes legacy over quick monetary gains. He urges associates to adopt an owner's mindset by evaluating equipment purchases through the lens of ROI and viewing board certification as a strategic investment in the practice's brand equity.

What'd you like? Send us a text.Take a break with Duck Logic and:TALK: Duck Logic in the Epstein files? A man who gets off when he has his diaper changed. Do you look at your poop? Tim challenges The Seahawks to Hungry Hungry Hippos. Gambling on anything. Someone stole Jim's poop joke. And sloths.SKETCHES: A last-minute Valentine gift that smells like one. Dairy humor from stand-up Sal Monella. Re-buying your childhood toys, sort of. ChatGPT comedy. Luge training. And more!

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Rhonda Spratt. Founder of Bella Duvet Goes Pink, a Georgia‑based breast cancer awareness nonprofit inspired by her mother’s battle with metastatic breast cancer. Rhonda explains how her mother’s passing drove her to build a year‑round awareness and support organization specifically focused on ensuring women stay vigilant outside of October. She discusses early detection, the emotional and physical realities of breast cancer, the creation of her “Pink Box” care packages, her personal journey of healing, and how she balances nonprofit work with a full‑time commercial real estate career and active lifestyle.

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Rhonda Spratt. Founder of Bella Duvet Goes Pink, a Georgia‑based breast cancer awareness nonprofit inspired by her mother’s battle with metastatic breast cancer. Rhonda explains how her mother’s passing drove her to build a year‑round awareness and support organization specifically focused on ensuring women stay vigilant outside of October. She discusses early detection, the emotional and physical realities of breast cancer, the creation of her “Pink Box” care packages, her personal journey of healing, and how she balances nonprofit work with a full‑time commercial real estate career and active lifestyle.

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Rhonda Spratt. Founder of Bella Duvet Goes Pink, a Georgia‑based breast cancer awareness nonprofit inspired by her mother’s battle with metastatic breast cancer. Rhonda explains how her mother’s passing drove her to build a year‑round awareness and support organization specifically focused on ensuring women stay vigilant outside of October. She discusses early detection, the emotional and physical realities of breast cancer, the creation of her “Pink Box” care packages, her personal journey of healing, and how she balances nonprofit work with a full‑time commercial real estate career and active lifestyle.

Send us a textMorning Prayer (Promise of God; Breast / Ovarian Cancer; Truth; Thanks be to God)Thank you for listening, our heart's prayer is for you and I to walk daily with Jesus, our joy and peace aimingforjesus.com YouTube Channel https://www.youtube.com/@aimingforjesus5346 Instagram https://www.instagram.com/aiming_for_jesus/ Threads https://www.threads.com/@aiming_for_jesus X https://x.com/AimingForJesus Tik Tok https://www.tiktok.com/@aiming.for.jesus

Join primary care physicians Kate Rowland, Gary Ferenchick, Henry Barry and Mark Ebell as they discuss 4 new POEMs (Patient Oriented Evidence that Matters): cardiovascular outcomes of GIPs (vs GLP), risk-based breast cancer screening (WISDOM Trial), whether a single dose of HPV vaccine is as good as two, and surgery (or not) for shoulder impingement syndrome. Plus Kate has a great Groundhog Day quiz!

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Sofia Diana Merajver, MD, PhD, a physician-scientist whose career bridges physics, medicine, and population health. Dr Merajver is the scientific director of the Breast Cancer Program, director of the Breast and Ovarian Cancer Risk Evaluation Program, and a professor of internal medicine and epidemiology at the University of Michigan Rogel Cancer Center in Ann Arbor. In this discussion, she reflected on a lifelong journey shaped by immigration, intellectual curiosity, and a commitment to science in service of human health.  

Season 5 continues at Octane 2026 with Dr. Kamakshi Zeidler. Breast enhancement is no longer just about augmentation. At Octane 2026, we sat down with Dr. Kamakshi Zeidler, one of the leaders redefining what modern breast enhancement looks like, and why 2026 is shaping up to be a major turning point. This conversation dives into how preservation-based techniques and injectable technologies are changing everything from recovery time to long term results, especially for patients who want natural outcomes without aggressive surgery. Key takeaways from this episode: Breast enhancement is shifting toward preservation, not destruction of anatomy Preserve techniques allow implants to be placed while maintaining ligaments and natural support Faster recovery, minimal anesthesia, and more stable long term results The growing role of AlloClae in sculpting cleavage and refinement, especially in thinner patients Why over-the-muscle implants are becoming safer and more predictable with newer implant technology How GLP-related body changes are influencing who benefits most from combination approaches The biggest trend heading into 2026: breast enhancement without general anesthesia and back to the gym in under a week This episode highlights how combining preservation techniques with next-generation injectable options is creating a completely new category of breast enhancement. Less trauma. More precision. Better longevity.

Welcome to part 2 of our health chat- this is continuing our conversation about our bodies and keeping them in check. As always we want you to pay attention to what your body is telling you because it does know you better than you think. Please have a listen and we hope that you gain something from this even if it is as simple as checking your breast!

Have you ever felt like you're drowning in a sea of conflicting parenting advice? One minute you're told you must do things one way, and the next, a "parenting expert" on TikTok tells you the exact opposite. It's enough to make any parent feel like they're failing before they've even begun. That is exactly why I am so thrilled to introduce our brand-new mini-series, Raising Eyebrows. My "partner in crime" for this journey is the wonderful Dr. Kailey Buller, a double board-certified physician in family and emergency medicine who has delivered hundreds of babies and lived through the newborn chaos herself. We are here to help you question authority, trust your gut, and finally dispel the myths, the meltdowns, and the misinformation that is roaming this world out of control.In this first episode, we're diving straight into one of the most polarizing topics in the parenting world: breastfeeding. We've all heard the "breast is best" mantras, but what happens when it just doesn't work for you? Dr. Kailey and I get real about our own "defective boobies" and why your maternal mental health and stress levels are actually far more important to your baby's well-being than the nutritional content of a single bottle. We talk about how the real keys to breastfeeding success aren't actually about your body at all — they're about your support system, your resources, and your time. It's time to stop the shame and recognize that formula is one of the most regulated foods on the planet; whether you breastfeed for a week or a year, your baby is going to be wonderful.We also pull a comb through the confusing world of starting solids, debunking the myth that you need to be a gourmet chef or spend three hours on meal prep. We share the truth about baby-led weaning, why "banana guacamole" might just be your baby's new favorite dish, and why gagging is a totally normal part of the learning process — not a sign that your baby is dying! Raising a child should be fun, and it starts when you stop comparing your "behind-the-scenes" to someone else's curated highlight reel. Remember, you are the answer to your child's needs, and as long as they are breathing, growing, and loved, you are doing a great job. Raise those eyebrows, question the noise, and join us as we bring some peace and laughter back into your parenting journey.Join me in our free "Be A Better Parent" Skool community at skool.com/beabetterparent. It's a place to find the truth, share the laughter, and realize that as long as your child is loved, you are doing a great job!Connect with Dr. Kailey: Visit VitalsWithDrBuller.com to find her socials and explore her evidence-based resources for surviving the "tiny human" years.Get the App: Stop the late-night doom-scrolling and ask your questions directly! Download the Be A Better Parent App today for quality, proven solutions.

Takeaways: - Care begins long before diagnosis.- Every four minutes a woman is diagnosed with breast cancer in India.- The fear of the unknown keeps women away from screenings.- 70-80% of breast cancer patients have no family history.- Know your breasts; self-examination is crucial.- Breast cancer is not a death sentence; it is treatable, especially when caught early.- Every year, gift yourself a preventive health checkup.- Normalize conversations about women's health at home and in society.- Empathy and communication are key in patient care.- Your health is as important as anyone else's; prioritize it.In this episode of Soul Velocity, host Snehal R Singh engages in a profound conversation with Dr. Namrata Singal Sawant, a breast consultant radiologist, about the critical importance of early detection and prevention in women's health, particularly concerning breast cancer. Dr. Namrata shares her personal journey, which began at the tender age of ten when she witnessed her grandmother succumb to breast cancer. This pivotal moment ignited her passion for women's health advocacy and early detection, leading her to explore the stark differences in breast cancer awareness and screening protocols between India and the United States. The discussion highlights the alarming statistics surrounding breast cancer in India, where many women are diagnosed at advanced stages due to a lack of awareness and cultural stigmas surrounding screenings.The conversation delves into the fears that prevent women from seeking preventive care, such as the fear of the unknown and misconceptions about mammography. Dr. Namrata emphasizes the importance of self-examination and regular screenings, urging women to prioritize their health and dispel the myths surrounding breast cancer. The episode concludes with a hopeful vision for the future of preventive healthcare in India, advocating for a cultural shift towards prioritizing women's health and normalizing conversations about breast cancer. Dr. Namrata's work aims to create a domino effect of awareness and early detection, ultimately saving lives and empowering women to take charge of their health.Programs by Snehal - https://linktr.ee/snehalrsinghAll books by MSW - https://linktr.ee/mindspiritworksLinkedIn - https://www.linkedin.com/in/snehalrsingh/Instagram - https://www.instagram.com/snehalrsinghInstagram - https://www.instagram.com/mindspiritworksFacebook - https://www.facebook.com/mindspiritworksllcYouTube - https://www.youtube.com/@SnehalRSinghCompany site - https://www.mindspiritworks.com/

Every five years, the U.S. dietary guidelines get updated. Usually, that update triggers some mix of frustration, disbelief and déjà vu. This time was different… not because the guidelines suddenly got human nutrition right, but because they moved slightly closer to reality. There's finally more emphasis on whole foods and less on ultra-processed junk. The old grain-heavy food pyramid has effectively been flipped. That alone is meaningful progress. If someone followed these guidelines instead of the Standard American Diet, they'd likely see improvements in weight, blood sugar and overall metabolic health. But "better than before" isn't the same as optimal. In this episode, I walk through what the new guidelines get right, and where they still fall short – especially for people who care about metabolic health, fertility, pregnancy, breastfeeding and raising resilient kids. One major issue is immediately evident: nutrient density and bioavailability are largely ignored.  The pyramid's Vitamin A recommendations focus on plant sources that require conversion, while the most reliable sources — animal foods like liver, eggs and dairy — are absent from the conversation.  Meanwhile, protein sources are treated as interchangeable, even though amino acid profiles, micronutrients, and absorption differ dramatically between animal and plant foods. Dairy is included, but without meaningful context around processing methods and individual tolerance. Baby formula is framed as an "alternative" to breast milk, without acknowledging the trade-offs. Fruits and vegetables are encouraged "throughout the day," quietly endorsing constant snacking while ignoring metabolic rest. None of this is accidental. These guidelines are political compromises more than they're based on physiological reality. They're designed to be broadly acceptable, not metabolically precise. The takeaway isn't to blindly reject the guidelines — it's to treat them as a starting point, not a finish line. Real health requires understanding food quality, preparation, sourcing, and context — not just categories on a chart. This episode is about learning where to think for yourself, where nuance matters, and why trusting labels or authority without questioning incentives has never been a winning strategy. Learn More: Everything you need to learn about the new food pyramid guidelines: https://www.usda.gov/about-usda/news/press-releases/2026/01/07/kennedy-rollins-unveil-historic-reset-us-nutrition-policy-put-real-food-back-center-health  We use MK Supplements organ meats to support nutrient density beyond the 2026 Food Pyramid. Use code YOUTUBE for 20% off your first order:

Send us a textThe first days of feeding a newborn can feel like a test you didn't study for: alarms go off every two hours, pumps take over your counter, and every ounce feels like a verdict. We open up about low milk supply, the pull to “keep trying,” and the quiet relief that comes from choosing what actually works for your baby and your life. No shaming, no perfect-parent script—just honest stories and practical paths forward.We dig into the real costs of chasing a plan that doesn't fit: hours spent researching pumps and flanges, returning to shift work with a cooler bag in hand, and the mental math of leaving tables to pump in cramped back offices. There's room here for the science and the context. Breast milk has well-documented benefits, yes, and there are safe, tested alternatives when your body says not today. We talk donor milk banks, how formula has evolved, and why cow's milk shouldn't replace breast milk or formula before age one. Along the way we unpack the long, messy history of feeding trends and remind ourselves that pressure often hides behind the word “support.”The heart of the conversation is a mindset shift: do the best you can with the resources you have right now and let that be perfect. That means asking your pediatrician for alternatives if advice doesn't fit your reality. It means measuring success by a fed baby, a calmer home, and a parent who still feels like a person. You're not required to carry a story about what would have happened 200 years ago. You are allowed to choose the option that keeps your family steady today.If this resonates, follow the show, share it with a friend who needs a kinder take on newborn feeding, and leave a quick review to help more parents find us. Your stories help others breathe easier—what choice brought you peace? Coaching offerKelly Hof: Labor Nurse + Birth CoachBasically, I'm your birth bestie! With me as your coach, you will tell fear to take a hike!Support the showConnect with Kelly at kellyhof.com Join the Bump & Beyond Online Community!https://www.facebook.com/groups/bumpnbeyondGrab The Book of Hormones on Amazon!Medical Disclaimer:This podcast is intended as a safe space for women to share their birth experiences. It is not intended to provide medical advice. Each woman's medical course of action is individual and may not appropriately transfer to another similar situation. Please speak to your medical provider before making any medical decisions. Additionally, it is important to keep in mind that evidence based practice evolves as our knowledge of science improves. To the best of my ability I will attempt to present the most current ACOG and AWHONN recommendations at the time the podcast is recorded, but that may not necessarily reflect the best practices at the time the podcast is heard. Additionally, guests sharing their stories have the right to autonomy in their medical decisions, and may share their choice to go against current practice recommendations. I intend to hold space for people to share their decisions. I will attempt to share the current recommendations so that my audience is informed, but it is up to each individual to choose what is best for them.

See omnystudio.com/listener for privacy information.

Takeaways: - Care begins long before diagnosis.- Every four minutes a woman is diagnosed with breast cancer in India.- The fear of the unknown keeps women away from screenings.- 70-80% of breast cancer patients have no family history.- Know your breasts; self-examination is crucial.- Breast cancer is not a death sentence; it is treatable, especially when caught early.- Every year, gift yourself a preventive health checkup.- Normalize conversations about women's health at home and in society.- Empathy and communication are key in patient care.- Your health is as important as anyone else's; prioritize it.In this episode of Soul Velocity, host Snehal R Singh engages in a profound conversation with Dr. Namrita Singhal Sawant, a breast consultant radiologist, about the critical importance of early detection and prevention in women's health, particularly concerning breast cancer. Dr. Namrita shares her personal journey, which began at the tender age of ten when she witnessed her grandmother succumb to breast cancer. This pivotal moment ignited her passion for women's health advocacy and early detection, leading her to explore the stark differences in breast cancer awareness and screening protocols between India and the United States. The discussion highlights the alarming statistics surrounding breast cancer in India, where many women are diagnosed at advanced stages due to a lack of awareness and cultural stigmas surrounding screenings.The conversation delves into the fears that prevent women from seeking preventive care, such as the fear of the unknown and misconceptions about mammography. Dr. Namrita emphasizes the importance of self-examination and regular screenings, urging women to prioritize their health and dispel the myths surrounding breast cancer. The episode concludes with a hopeful vision for the future of preventive healthcare in India, advocating for a cultural shift towards prioritizing women's health and normalizing conversations about breast cancer. Dr. Namrita's work aims to create a domino effect of awareness and early detection, ultimately saving lives and empowering women to take charge of their health.Programs by Snehal - https://linktr.ee/snehalrsinghAll books by MSW - https://linktr.ee/mindspiritworksLinkedIn - https://www.linkedin.com/in/snehalrsingh/Instagram - https://www.instagram.com/snehalrsinghInstagram - https://www.instagram.com/mindspiritworksFacebook - https://www.facebook.com/mindspiritworksllcYouTube - https://www.youtube.com/@SnehalRSinghCompany site - https://www.mindspiritworks.com/

Full article: Commercial Artificial Intelligence (AI) Tool for Screening Digital Breast Tomosynthesis: Factors Associated With AI-Based Breast Cancer Detection Research into breast imaging artificial intelligence (AI) has focused primarily on digital mammography. Hira Qureshi, MD, discusses the AJR article by Bahl et al. that explores the performance of a commercial AI system for digital breast tomosynthesis evaluation.

Breast cancer is being diagnosed in younger women more than in the past. There is new research that explores how physical activity may lower future breast cancer risk for girls. Adult women who are highly engaged in recreational physical activity have a roughly 20% reduction in breast cancer risk compared to less active women, according to reporting in the Deseret News. Lois Collins, with the Deseret News joins the show to explain the details.

Submit your question and we'll answer it in a future episode!Join our Patreon Community!https://www.patreon.com/badassbreastfeedingpodcastThis week's episode is also brought to you by Nursing Queen; stylish nursing clothes that will make your life easier and that you'll want to wear long after your nursing days are over. Use promo code BADASS for 10% off your purchase at www.nursingqueen.com.Today Dianne and Abby are discussing breastfeeding tools, what is useful andwhat you may not ever need for breastfeeding. Are all the tools necessary? Findout on today's episode!If you are a new listener, we would love to hear from you.  Please consider leavingus a review on iTunes or sending us an email with your suggestions and commentsto badassbreastfeedingpodcast@gmail.com. You can also add your email to ourlist and have episodes sent right to your inbox!Things we talked about: Breastfeeding pillows [6:25]Nipple creams [11:39]Breast pads [13:37]Breast pumps [15:20]Abby needs photos! [21:30]Storage Bags [21:58]Nipple shields [23:08]Supplemental nursing system [26:08]Supplement tools [28:37]Pumping bra and nursing bra [31:29]Links to information we discussed or episodes you should check out!https://badassbreastfeedingpodcast.com/episode/nipple-shields/https://badassbreastfeedingpodcast.com/episode/infant-sleep-with-rebecca-michi/Set up your consultation with Diannehttps://badassbreastfeedingpodcast.com/consultations/Check out Dianne's blog here:https://diannecassidyconsulting.com/milklytheblog/Follow our Podcast:https://badassbreastfeedingpodcast.comHere is how you can connect with Dianne and Abby:AbbyTheuring ,https://www.thebadassbreastfeeder.comDianne Cassidy @diannecassidyibclc, http://www.diannecassidyconsulting.comMusic we use:Music: Levels of Greatness from We Used to Paint Stars in the Sky (2012)courtesy of Scott Holmes at freemusicarchive.org/music/ScottHolmes

Oprah's new book encourages followers to “free themselves” from “shame and blame” by accessing weight loss meds; Her claim “it's the obesity gene” is put to the test by twin studies; Study shows brain stimulation with external electronic headset produces weight loss rivaling shots, pills; Ultra-processed food ups daily calorie intake by 500; Breast-feeding moms gain less post-pregnancy weight; Solutions for  Myelodysplastic Syndrome; Scientists find hidden weight gain trigger in soybean oil.

Hair disasters! More "non-negotiables" - the things that happen in your home (catchphrases, actions, responses) that no-one outside would understand. Gym etiquette! And more turning 40 thoughts for Maria! Enjoy! xx Please subscribe, follow, and leave a review. xxx You can find us in all places here; ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://podfollow.com/lifewithnat/view⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We're on Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/lifewithnatpod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Nat's insta: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@natcass1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Marc's insta: ⁠⁠⁠⁠⁠⁠@camera_marc⁠⁠⁠⁠⁠⁠ Niece's insta: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@natsnieces⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Tony's insta: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@tonycass68⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Linny's insta: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@auntielinny.lwn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ MORE LIVE SHOWS! 07/02/2026 Brighton, The Forge ⁠⁠⁠⁠⁠⁠TICKETS⁠⁠⁠⁠⁠⁠ 08/02/2026 Newcastle upon Tyne, The Stand ⁠⁠⁠⁠⁠⁠TICKETS⁠⁠⁠⁠⁠⁠ 25/02/2026 Folkestone, Quarterhouse ⁠⁠⁠⁠⁠⁠TICKETS⁠⁠⁠⁠⁠⁠ 28/02/2026 Colchester, Arts Centre ⁠⁠⁠⁠⁠⁠TICKETS⁠⁠⁠⁠⁠⁠ 07/03/2026 Manchester, Fairfield Social Club ⁠⁠⁠⁠⁠⁠TICKETS⁠⁠⁠⁠⁠⁠ 22/03/2026 Leeds, The Wardrobe ⁠⁠⁠⁠⁠⁠TICKETS⁠⁠⁠⁠⁠⁠ 29/03/2026 Bristol, The Gaffe - ⁠⁠⁠⁠⁠⁠TICKETS⁠⁠⁠⁠⁠⁠ Book Club: January's Book - ⁠⁠⁠⁠Wintering by Katherine May⁠⁠⁠⁠ Nat's solo chats - any rants always welcome. We're talking big career changes, the constant comparisons with others on social media... and the audacity of teenagers! Scraping the Barrel - SCAN AND SHOP VIRGIN NO LONGER! Bonce vs list! - Are you a list maker? Always collecting for Nostalgia Fest! What's brewing with the Nieces - AGEING & non-negotiables Things we're nagging with Linny about - More lateness stories and some cleaning questions, please! The Tony talks chatter - Keep your DIY questions coming A 'Keep It Light Media' Production Sales, advertising, and general enquiries: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠hello@keepitlightmedia.com⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Merrill is a Breast surgeon and a leader in the Physician Just Equity (PJE) program that advocates for physicians who are in employment situations that are hostile, discriminatory, or intensely conflictual. Oftentimes, physicians have nowhere to turn, and PJE helps them navigate these environments by providing support (not legal advice). She is also an art lover, photographer, baker, writer, foodie, and more. Join us in conversation.Scrubbedoutsurgeon.com and @scrubbedoutsurgeon on InstagramJoin the Doctor's Art School at https://www.skool.com/thedoctorsartschool

Cynthia Thurlow breaks down the conflicting information around mammograms, cancer risk and screening choices so women can make empowered, evidence-driven decisions about their breast health. We cover: If mammograms remain the gold standard for breast cancer screening The radiation reality and should we be concerned Is there really overscreening and overdiagnosing The limitations of alternative screening services The real lifestyle drivers of breast cancer risk that deserve attention   Cynthia Thurlow is a nurse practitioner, host of the Everyday Wellness podcast, author and international speaker, with over 15 million views for her second TEDx talk (Intermittent Fasting: Transformational Technique). With over 25 years experience in health and wellness, Cynthia is a globally recognized expert in perimenopause/menopause and intermittent fasting, and has been featured on ABC, FOX5, KTLA, CW, Medium, Entrepreneur, and The Megyn Kelly Show. Her mission is to help empower women to live their most optimal lives in perimenopause and beyond.   Supplements themidlifepause.com  Discount code ZORA 10% off HRT Guide: cynthiathurlow.com/hrt Contact Cynthia Thurlow Twitter: https://twitter.com/CynthiaThurlow Instagram: https://www.instagram.com/cynthia_thurlow___/ Facebook: https://www.facebook.com/groups/1004505663061383 LinkedIn: https://www.linkedin.com/in/cynthia-thurlow-50395a9/ https://www.tiktok.com/@cynthia_thurlow_ Youtube: https://www.youtube.com/cynthiathurlow Website: https://cynthiathurlow.com/ Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here - https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - http://oxfordhealthspan.com/discount/ZORA Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora Try Suji to improve muscle 10% off with code ZORA at TrySuji.com - https://trysuji.com Try OneSkin skincare with code ZORA for 15% off https://oneskin.pxf.io/c/3974954/2885171/31050   Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠   Biohacking Menopause Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠    For partnership inquiries: https://www.category3.ca/  Some episodes of Hack My Age are supported by partners whose products or services may be discussed during the show. The host may receive compensation or earn a minor commission if you purchase through affiliate links at no extra cost to you. All opinions shared are those of the host and guests, based on personal experience and research, and do not necessarily represent the views of any sponsor. Sponsorships do not imply medical endorsement or approval by any healthcare provider featured on this podcast.

335: Seth Gruber is back for a second time to finish up what we started last year in 2025, which was quite literally the most controversial podcast episode I have done to date, and for good reason. Abortion, both surgical and oral pill abortions, are performed daily across the USA and, sadly, the world, often without any informed consent about what an abortion can do to a woman's health. This information has been suppressed, and the studies, research, and real life stories from mothers have been suppressed. Today we get into who has financial ties to Planned Parenthood, why Big Pharma is pushing the abortion pill that is actually more dangerous than having a surgical abortion, as well as preterm labor complications linked to past abortions, and ultimately why and how women are simply not informed by their doctors and OBGYNs about the deadly complications for the women considering an abortion. Whether you're on the right, the left, or somewhere in the middle, I can guarantee the information in today's episode will shock you, and you will be demanding more truth from your doctors and questioning what we have all been told for decades and the true agenda behind aborting babies despite women's health being at risk. → Episode 286 with Seth Gruber Topics Discussed: → The abortion pill vs. surgical abortion → Breast cancer linked to past abortions → Studies that have been suppressed → Who funds Planned Parenthood → Why the health effects of miscarriages are not the same as those from abortions → When does a human become a human? → Baby parts in our drinking water → Playboy is linked to Planned Parenthood?! → How to save a baby after the abortion pill is taken → Preterm labor As always, if you have any questions for the show please email us at digestthispod@gmail.com. And if you like this show, please share it, rate it, review it and subscribe to it on your favorite podcast app.  Sponsored By:  → Our Place | Go to https://fromourplace.com/ and use code DIGEST for 10% Check Out Seth Gruber: → Website → YouTube → Instagram → Rumble → The 1916 Project → The Seth Gruber Show Podcast → Events Check Out Bethany: → Bethany's Instagram: @lilsipper → YouTube → Bethany's Website → Discounts & My Favorite Products → My Digestive Support Protein Powder → Gut Reset Book  → Get my Newsletters (Friday Finds) Learn more about your ad choices. Visit megaphone.fm/adchoices

Behind the Knife ABSITE 2026 – Up-to-date and high yield learning to help you DOMINATE the exam. Don't forget to check out our ABSITE Podcast Companion Book available on Amazon: https://www.amazon.com/Behind-Knife-ABSITE-Podcast-Companion/dp/B0CLDQWZG3/ref=monarch_sidesheet Be sure to check out our free study aid, which includes all 32 review episodes, brief written summaries, high yield images, and flash cards. Simply create an account on our iOS or Android app or on our website and you will find the entire course in your Library.  Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Google Play App Store: https://play.google.com/store/apps/details?id=com.btk.app Behind the Knife would like to sincerely thank Medtronic for sponsoring the entire 2026 ABSITE podcast series.  Medtronic has a rich history of supporting surgical education, and we couldn't be happier that they chose to partner with Behind the Knife.  Learn more at https://www.medtronic.com/en-us/index.html If you like the work that Behind the Knife is doing, please leave us a review wherever you listen to podcasts.   Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   Check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Behind the Knife in Español - repaso para el examen de certificación en cirugía general: https://app.behindtheknife.org/premium/repaso-para-el-examen-de-certificaci-n-en-cirug-a-general